Archives for July 2010
Engage with independent insights, opinions, and analysis from an array of leaders in cardiology.
Jean Costello, CardioExchange Staff
We’ve redesigned CardioExchange based on your participation and feedback! You’ll see a new look and feel, and functionality to make it easier to join the dialogue. New Ways to Connect with the CardioExchange Community The site includes two important new features to help you get the most out of your time on CardioExchange: The Recent Activity feed, and Following. The Recent Activity feed Front and center, the Recent Activity shows you what is happening right now on CardioExchange. Similar to the Newsfeed on Facebook or Network Activity on LinkedIn, Recent… Continue Reading
Larry Husten, PhD
Source is CardioExchange News, unless otherwise noted. FDA Releases Briefing Documents for Avandia Panel, 09 Jul 2010 More Evidence Goes Against Avandia, 28 Jun 2010 FDA Panels to Review Rosiglitazone and Dabigatran, 10 Jun 2010 CANOE Paddles Into the Avandia Storm, 03 Jun 2010 European Heart Journal Editors Defend Nissen Editorial, 03 May 2010 Industry Affiliation and Position on the Rosiglitazone Controversy, 20 Apr 2010, Journal Watch, Paul S. Mueller, MD, MPH, FACP Will the FDA Halt Avandia Safety Study?, 19 Apr 2010 Rosiglitazone: When Evidence Is Inconclusive Even After… Continue Reading